The Gonorrhea Treatment Market in 2026 is increasingly focused on combination antibiotic therapy strategies as a means of reducing the risk of treatment failure and slowing the emergence of resistance to last-line agents. Dual therapy regimens combining ceftriaxone with azithromycin have been the dominant approach in many national guidelines, though azithromycin resistance has undermined...